NON APPLICABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30.06.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has submitted a certificate to the BSE confirming that Regulation 57(5) of the SEBI Listing Regulations does not apply to the company for the quarter ended 30 June 2025. This regulation is meant for companies that have listed non-convertible debt securities or non-convertible redeemable preference shares, requiring them to certify timely payment of interest or principal. The filing essentially means the company has no such listed debt or preference share obligations outstanding during this period. This is a routine quarterly compliance submission.
This is a routine regulatory filing with no material impact on shareholders or the stock price. It simply confirms the company has no listed debt or preference share instruments requiring this disclosure.